Synchrony Financial: UBS cuts target price to $80 from $81
SYF•UBS cut its target price for Synchrony Financial to $80 from $81.
Related News
Theriva Biologics announces sale of Syn-004 and related enzyme portfolio to Biossil Labs
TOVX•
Colony Bankcorp announces completion of merger with First Reliance Bancshares
CBAN•
Stratum maintains goal of achieving profitability in 2027
SRTM•
L.B. Foster Company announces executive officer changes
FSTR•
Nasdaq trade halt: volatility trading pause at 9:40 a.m.
PMN•